NEXALIN TECHNOLOGY INC (NXL) Stock Price, Quote, News and Overview
NASDAQ:NXL - Nasdaq - US65345B2016 - Common Stock - Currency: USD
NXL Quote, Performance and Key Statistics
NEXALIN TECHNOLOGY INC
NASDAQ:NXL (1/27/2025, 10:58:46 AM)
2.65
-0.07 (-2.57%)
The current stock price of NXL is 2.65 USD. In the past month the price increased by 3.82%. In the past year, price increased by 675.81%.
NXL Latest News, Press Releases and Analysis
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
HOUSTON, TX, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors...
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025
DIFS Technology: A Potential Game-Changer for Mental Health Treatments Setting New Benchmarks: 65% Response Rate Shown in Completed Depression Trials ...
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2...
NXL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.58 | 223.40B | ||
| ISRG | INTUITIVE SURGICAL INC | 78.62 | 205.27B | ||
| SYK | STRYKER CORP | 34.02 | 150.95B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.89 | 149.18B | ||
| MDT | MEDTRONIC PLC | 17.38 | 116.99B | ||
| BDX | BECTON DICKINSON AND CO | 18.73 | 71.48B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 21.06 | 40.60B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.68 | 40.44B | ||
| RMD | RESMED INC | 30.88 | 37.57B | ||
| IDXX | IDEXX LABORATORIES INC | 39.04 | 35.01B | ||
| DXCM | DEXCOM INC | 52.09 | 34.59B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.16 | 25.58B |
Related stock screener links
About NXL
Company Profile
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California and currently employs 6 full-time employees. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. The company also has designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Generation 3 or Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
Company Info
NEXALIN TECHNOLOGY INC
26072 Merit Circle, Suite 106
Laguna Niguel CALIFORNIA US
Employees: 6
Company Website: https://nexalin.com
Investor Relations: https://nexalin.com/investors/
Phone: 19492608090
NXL FAQ
What is the stock price of NXL?
The current stock price of NXL is 2.65 USD.
What is the symbol for NEXALIN TECHNOLOGY INC stock?
The exchange symbol of NEXALIN TECHNOLOGY INC is NXL and it is listed on the Nasdaq exchange.
On which exchange is NXL stock listed?
NXL stock is listed on the Nasdaq exchange.
Is NXL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NXL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NXL.
Does NXL stock pay dividends?
NXL does not pay a dividend.
What is the Price/Earnings (PE) ratio of NXL?
NXL does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).
What is the Short Interest ratio of NXL stock?
The outstanding short interest for NXL is 3.08% of its float.
NXL Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NXL. When comparing the yearly performance of all stocks, NXL is one of the better performing stocks in the market, outperforming 99.25% of all stocks.
NXL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NXL. While NXL has a great health rating, there are worries on its profitability.
NXL Financial Highlights
Over the last trailing twelve months NXL reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by -3.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -105.66% | ||
| ROE | -112.04% | ||
| Debt/Equity | 0 |
NXL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to NXL. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 2.5% and a revenue growth 56.86% for NXL